Roffman Miller Associates Inc. PA Has $6.68 Million Position in Danaher Corporation $DHR

Roffman Miller Associates Inc. PA cut its holdings in Danaher Corporation (NYSE:DHR) by 7.0% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,809 shares of the conglomerate’s stock after selling 2,533 shares during the quarter. Roffman Miller Associates Inc. PA’s holdings in Danaher were worth $6,679,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Pacific Capital Partners Ltd bought a new position in Danaher during the first quarter valued at about $7,175,000. Brookstone Capital Management increased its holdings in shares of Danaher by 7.0% during the 1st quarter. Brookstone Capital Management now owns 11,080 shares of the conglomerate’s stock valued at $2,271,000 after acquiring an additional 723 shares during the last quarter. World Investment Advisors increased its holdings in shares of Danaher by 13.8% during the 1st quarter. World Investment Advisors now owns 15,879 shares of the conglomerate’s stock valued at $3,255,000 after acquiring an additional 1,923 shares during the last quarter. Concurrent Investment Advisors LLC raised its stake in shares of Danaher by 193.2% in the 1st quarter. Concurrent Investment Advisors LLC now owns 10,048 shares of the conglomerate’s stock valued at $2,060,000 after acquiring an additional 6,621 shares in the last quarter. Finally, Envestnet Asset Management Inc. lifted its holdings in Danaher by 14.1% in the 1st quarter. Envestnet Asset Management Inc. now owns 1,261,196 shares of the conglomerate’s stock worth $258,545,000 after purchasing an additional 155,537 shares during the last quarter. 79.05% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have commented on the company. Royal Bank Of Canada set a $241.00 price target on Danaher in a report on Tuesday, September 2nd. UBS Group decreased their price objective on shares of Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a report on Wednesday, July 23rd. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research note on Wednesday, October 8th. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a report on Sunday. Finally, Redburn Partners set a $220.00 price target on shares of Danaher in a report on Wednesday, October 8th. Eighteen analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $243.39.

Danaher Trading Down 0.6%

Shares of DHR stock opened at $214.10 on Tuesday. The firm has a market capitalization of $151.23 billion, a P/E ratio of 44.14, a price-to-earnings-growth ratio of 3.28 and a beta of 0.77. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23. The firm’s fifty day simple moving average is $203.53 and its 200 day simple moving average is $199.79. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to the consensus estimate of $6 billion. During the same period in the prior year, the firm earned $1.71 EPS. The business’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, sell-side analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.6%. The ex-dividend date was Friday, September 26th. Danaher’s payout ratio is currently 26.39%.

Insider Buying and Selling

In other Danaher news, Director Teri List sold 2,778 shares of the firm’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the sale, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This trade represents a 11.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.